Stay updated on Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Sign up to get notified when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page

  1. Check
    yesterday
    No Change Detected
  2. Check
    8 days ago
    No Change Detected
  3. Check
    16 days ago
    Change Detected
    Summary
    The page footer revision identifier was updated from v3.5.2 to v3.5.3, reflecting a site versioning change rather than a change to the clinical trial information.
    Difference
    0.0%
    Check dated 2026-04-27T11:51:48.000Z thumbnail image
  4. Check
    23 days ago
    Change Detected
    Summary
    Added Revision: v3.5.2; Deleted Revision: v3.5.0.
    Difference
    0.0%
    Check dated 2026-04-20T05:57:08.000Z thumbnail image
  5. Check
    51 days ago
    Change Detected
    Summary
    Revision updated from v3.4.3 to v3.5.0.
    Difference
    0.0%
    Check dated 2026-03-22T22:15:35.000Z thumbnail image
  6. Check
    66 days ago
    Change Detected
    Summary
    Revision history updated to include v3.4.3 and remove v3.4.2.
    Difference
    0.0%
    Check dated 2026-03-08T12:36:41.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    Revision updated from v3.4.1 to v3.4.2, which appears to be a minor system or UI update with no changes to study data or user-facing content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-14T14:33:23.000Z thumbnail image
  8. Check
    95 days ago
    Change Detected
    Summary
    Revision updated from v3.4.0 to v3.4.1, indicating a minor update. No visible changes to user-facing content were observed.
    Difference
    0.0%
    Check dated 2026-02-07T09:00:59.000Z thumbnail image

Stay in the know with updates to Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Olaparib & Atezolizumab in BRCA+ Breast Cancer Clinical Trial page.